πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe β€” grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≀24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β€” use filters for patent-cliff planning.

Page 54 of 78

  1. US 7838216

    Human gene related to but distinct from EGF receptor gene

    Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7838531

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7834005

    Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto

    Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7833533

    Enhanced antiviral activity against foot and mouth disease

    Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7829102

    Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7825216

    Phenylanine derivatives

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7824682

    Cardiac myosin light chain kinase-specific antibodies and methods of detecting

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7824695

    Delivery of proteins across polar epithelial cell layers

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7825092

    Dendroaspis natriuretic peptide for treatment of cancer

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7825096

    O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7825126

    Purine derivatives as A3 and A1 adenosine receptor agonists

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7825159

    Mixtures of aromatic esters for marking or tagging organic products, marker compositions comprising the same and manufacturing methods thereof

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7824690

    Marek's disease virus vaccine

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7824681

    Human monoclonal antibodies that specifically bind IGF-II

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7825154

    Small molecule inhibitors of botulinum neurotoxins

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7820182

    Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7820642

    Nandrolone 17Ξ²-carbonates

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7820174

    T cell receptors and related materials and methods of use

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7820181

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7820395

    Orientia tsutsugamushi truncated recombinant outer membrane protein (R47) and (R56) vaccines diagnostics and therapeutics for scrub typhus

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7815916

    Cloning and expression of HTLV-III DNA

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7816087

    Gene expressed in prostate cancer and methods of use

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7816560

    Long chain n-alkyl compounds and oxa-derivatives thereof

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7811550

    Method for making magnetic fluorescent core shell nanoparticles

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7811998

    Novobiocin analogues as anticancer agents

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7812117

    Vasostatin as marrow protectant

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7807458

    Multilineage-inducible cells and uses thereof

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7807805

    Melanoma antigens and their use in diagnostic and therapeutic methods

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7807174

    Class of therapeutic protein based molecules

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7803380

    Compositions and methods for diagnosis and treatment of tumors

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7803913

    Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7803386

    Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7803614

    Melanoma antigens and their use in diagnostic and therapeutic methods

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7794998

    Primate T-lymphotropic viruses

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7795208

    Methods of using deacetylase inhibitors to promote cell differentiation and regeneration

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7794714

    Newcastle disease virus monoclonal antibodies

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7790181

    Live attenuated viral vaccines for Eastern Equine Encephalitis virus

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7790186

    Plasmodium vivax hybrid circumsporozoite protein and vaccine

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7790182

    Protein vaccines against poxviruses

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7790735

    Methanocarba cycloalkyl nucleoside analogues

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7790473

    Biofunctionalized quantum dots for biological imaging

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7790764

    Biologically active macrolides, compositions, and uses thereof

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7786285

    Recombinant vaccine against botulinum neurotoxin

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7785565

    Metal chelators and methods of their use

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7780966

    Artificial invaplex

    Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7781445

    Synthesis of indenoisoquinoliniums and methods of use

    Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7777019

    Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7776607

    Mammalian selenoprotein differentially expressed in tumor cells

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.